ART ICR Saliva Test To Detect Genetic... - Active Surveillan...

Active Surveillance - Prostate Cancer

655 members366 posts

ART ICR Saliva Test To Detect Genetic Variants Linked To High Risk, Aggressive PCa

RMontana profile image
0 Replies

ART ICR Saliva Test To Detect Genetic Variants Linked To High Risk, Aggressive PCa

• A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one group of men than the current standard blood test (PSA)

o For the men with the highest genetic risk, the PRS test falsely identified fewer people with prostate cancer than the PSA test,

o picked up people with cancer who would have been missed by the PSA test alone, and

o picked up a higher proportion of the aggressive cancers than the PSA test.

• The researchers are presenting findings from the study at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

o The study calculated the polygenic risk score (PRS) of 6,142 European men recruited from their GP surgeries

o The score is based on 130 genetic variations in the DNA code that are linked to prostate cancer

o an international team has identified more risk variants for men of Asian and African ancestry

• 558 men high risk men were invited to further screening, including MRI n Biopsy.

o 187 (34 per cent) with a high PRS were diagnosed with prostate cancer, vs

o 140 (25 per cent) of the 558 men who had prostate cancer found with a PSA test only.

o PRS was therefore 34% more likely to find PCa than PSA, and

> 147 (77.8 per cent) of the 187 men had a PSA below 3.0ug/L (ng/mL)

> this PSA is considered ‘normal’ and no further treatment would have followed

> 55.1% were aggressive cancers; only 35.5% of these were identified by PSA test

> PRS was 55% more effective in identifying aggressive PCa’s than PSA

• PRS test is more accurate than MRI in men with high genetic risk,

o 119 men (63.6 per cent) of the 187 had prostate cancer confirmed by a biopsy

o this PCa was not detected by the MRI.

• PRS saliva test could offer an additional screening tool to be offered to men at higher risk

• TRANSFORM trial will compare the PRS saliva test to the PSA blood test and MRI scan

• PRS is a simple, cheap, spit test used to identify men at higher risk with PCa due to their genetic makeup; an effective tool to catch the PCa early

icr.ac.uk/news-archive/asco...

Written by
RMontana profile image
RMontana
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

ART How to Increase TET Naturally; Dr Rena Malik, M.D.

ART How to Increase TET Naturally; Dr Rena Malik, M.D. Here is a good set of 5 recommendations on...

ART AACR Journal ; Effect of Sulforaphane in Men with BCR after Radical Prostatectomy

I have posted an NIH study with similar findings and have noted that I have taken 20mg of...

Most Recent MRI

Hello everyone, I am 72 and have been on active surveillance for prostate cancer since I was...

Contrast MRI vs biopsy

Just wanted to share my experience with contrast pelvic/prostate 3T MRI and prostate 14 core biopsy...

Biopsies

I am nine years out since diagnosis of a very low-risk Gleason 6 tumor. It was found in a single...